EGFR and urinary bladder cancer: 15 studies consisting of 3,290 samples of Bladder cancer, Endometrial cancer, Melanoma and Non-small cell lung cancer were run in OncoPrint to find Alteration frequency of EGFR, HRAS and MAPK3 (Fig. 5).